There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

Novartis Acquires Genoptix; Lilly Exec Becomes Savient CEO; and More.

Week of Jan. 24, 2011: Company and People Notes: Novartis Acquires Genoptix; Lilly Exec Becomes Savient CEO; and More.

FDA published its long-awaited guidance titled Process Validation: General Principles and Practices this week.

FDA Publishes Revised Process-Validation Guidance

Merck Teams with Parexel; Roche CFO to Retire; and More

Week of Jan. 17, 2011: Company and People Notes: Merck Teams with Parexel; Roche CFO to Retire; and More.

A company's contamination-control plan is an important document designed to formalize the rationale, methods, and validation of contamination-control procedures in a manufacturing facility. The author describes the role of bioburden in the contamination-control plan.

The Role of Bioburden in the Contamination-Control Plan

Improvements in analytical techniques may call for a re-evaluation of the biopharmaceutical industry saying that "the process is the product."

What's More Important, the Process or the Product?

UHPLC offers increased performance compared with HPLC, including shorter analysis times and increased sensitivity.

The Use Of UHPLC In Post-Drug Development

Gilead Sciences to Acquire Arresto Biosciences; Sartorius Appoints Head of Lab Business; and More.

Week of Jan. 3, 2011: Company and People Notes: Gilead Sciences to Acquire Arresto Biosciences; Sartorius Appoints Head of Lab Business; and More.

Expert and implementation working groups harmonize more guidelines and move Q11 forward.

Inside ICH: ICH Meets in Japan to Finalize Key Documents

Michelle Hoffman, editorial director of Pharmaceutical Technology.

Capable of great works, pharma as a whole still yields to the lesser angels of its nature.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes